Vimarsana
Biggest News Aggregation in the World

Allogene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allogene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allogene Today - Breaking & Trending Today

Allogene Therapeutics To Lay Off 22% Of Its Workforce; Stock Down - Vimarsana News

Allogene Therapeutics To Lay Off 22% Of Its Workforce; Stock Down

Gene editing company, Allogene Therapeutics, Inc. (ALLO), Friday announced its decision to cut down its workforce by 22% in a move to focus on developing its blood cancer therapy.

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B cell Lymphoma at the American Society of Clinical Oncology Annual Meeting - Vimarsana News

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B cell Lymphoma at the American Society of Clinical Oncology Annual Meeting

SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, today presented long-term follow up... | June 5, 2023

Allogene Therapeutics, Inc.: Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting - Vimarsana News

Allogene Therapeutics, Inc.: Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

Long Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrate Potential of Allogeneic CD19 CAR T to Generate Durable Complete Responses Similar to Approved Autologous Therapies Presentation Focused

Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences - Vimarsana News

Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 24, 2023 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, today... | May 24, 2023

Moore Kuehn, PLLC Encourages Investors of Allogene - Vimarsana News

Moore Kuehn, PLLC Encourages Investors of Allogene

NEW YORK, Jan. 22, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers...